HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Anna Paola Leporace Selected Research

Stroke (Strokes)

1/2023Determinants of frontline tyrosine kinase inhibitor choice for patients with chronic-phase chronic myeloid leukemia: A study from the Registro Italiano LMC and Campus CML.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Anna Paola Leporace Research Topics

Disease

1Chronic Obstructive Pulmonary Disease (COPD)
01/2023
1BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia)
01/2023
1Myocardial Ischemia (Ischemic Heart Diseases)
01/2023
1Stroke (Strokes)
01/2023
1Hypertension (High Blood Pressure)
01/2023
1Neoplasms (Cancer)
01/2023
1Autoimmune Hemolytic Anemia (Cold Agglutinin Disease)
01/2018
1Hemolysis
11/2014

Drug/Important Bio-Agent (IBA)

1Imatinib Mesylate (Gleevec)FDA Link
01/2023
1Dasatinib (BMS 354825)FDA Link
01/2023
1Tyrosine Kinase InhibitorsIBA
01/2023
1nilotinibFDA Link
01/2023

Therapy/Procedure

1Therapeutics
01/2018
1Splenectomy
11/2014